logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11033559 B1

PDFFull Text
Expired
Date of Patent:
Jun. 15, 2021

Filed:

Sep. 29, 2016

Leukocyte infiltration promoting agent and antitumor immunostimulatory agent

Applicant:

Osaka University, Osaka, JP;

Inventors:

Nobuyuki Takakura, Osaka, JP;

Hisamichi Naito, Osaka, JP;

Kazuhiro Takara, Osaka, JP;

Assignee:

OSAKA UNIVERSITY, Osaka, JP;

Attorney:

Wenderoth, Lind & Ponack, L.L.P.

Primary Examiner:

Ilia I Ouspenski

Int. Cl.
CPC ...
A61K 31/662 (2006.01); A61K 31/685 (2006.01); A61P 35/00 (2006.01); A61P 37/04 (2006.01); A61K 45/00 (2006.01); A61K 31/683 (2006.01); A61K 35/17 (2015.01); A61K 38/00 (2006.01); A61K 39/395 (2006.01);
U.S. Cl.
CPC ...
A61K 31/662 (2013.01); A61K 31/683 (2013.01); A61K 31/685 (2013.01); A61K 35/17 (2013.01); A61K 38/005 (2013.01); A61K 39/39558 (2013.01); A61K 45/00 (2013.01); A61K 45/05 (2013.01); A61P 35/00 (2018.01); A61P 37/04 (2018.01);
Abstract

A lysophospholipid receptor-activating substance is able to normalize abnormal blood vessels in tumors without affecting normal blood vessels and to thus induce or promote infiltration of leukocytes into the whole or partial region of a tumor. Therefore, such a lysophospholipid receptor-activating substance is useful as a leukocyte infiltration promoter and an antitumor immunostimulant. Moreover, such a lysophospholipid receptor-activating substance can enhance cancer immunotherapy when used in combination with cancer immunotherapy, and is therefore useful as an agent for enhancing cancer immunotherapy.

Find Patent Forward Citations

Takakura, Nobuyuki. (2021). Leukocyte infiltration promoting agent and antitumor immunostimulatory agent (U.S. Patent No. 11033559). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11033559

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…